BioAge Labs, Inc.

United States of America

 
Total IP 40
Total IP Rank # 35,593
IP Activity Score 2.6/5.0    52
IP Activity Rank # 14,134
Stock Symbol BIOA (nasdaq)
Market Cap. 674M  (USD)

Patents

Trademarks

21 0
6 0
13 0
0
 
Last Patent 2025 - Nlrp3 variants & library screen ...
First Patent 2018 - Survival prediction using metabo...

Latest Inventions, Goods, Services

2024 Invention Nlrp3 variants & library screen for nlrp3 inhibitors with the same. The present invention relate...
Invention Nlrp3 variants & library screen for nlrp3 inhibitors with the same. The present invention relates...
Invention N-oxide inhibitors of nlrp3 inflammasome. The present disclosure relates to compounds that act a...
Invention Crystalline and salt forms of an nlrp3 inhibitor. This disclosure provides crystalline forms of a...
Invention Crystalline and salt forms of an nlrp3 inhibitor. This disclosure provides crystalline forms of ...
Invention Combination therapy of apelin receptor agonist and glp-1 receptor agonist for treating a disease ...
2023 Invention Apelin receptor modulators for treating muscle conditions. Apelin receptor modulators can improv...
Invention Apelin receptor agonists for treating muscle conditions. Apelin receptor modulators can improve p...
Invention Indazole and pyrazolopyridine compounds as inhibitors of nlrp3 inflammasome. The present disclos...
Invention Indazole and pyrazolopyridine compounds as inhibitors of nlrp3 inflammasome. The present disclosu...
Invention N-oxide inhibitors of nlrp3 inflammasome. The present disclosure relates to compounds that act as...
Invention Inhibitors of nlrp3 inflammasome. The present disclosure relates to compounds that act as inhibit...
Invention Inhibitors of nlrp3 inflammasome. The present disclosure relates to compounds that act as inhibi...
Invention Apelin receptor modulators for treatment of a disorder or disease associated with bbb permeabilit...
Invention Apelin receptor modulators for treatment of a disorder or disease associated with bbb permeability
Invention Survival prediction using metabolomic profiles. In various embodiments, the present description ...
2022 Invention Rage fusion proteins with improved stability and ligand binding affinity and uses thereof. The p...
Invention Apelin receptor modulators for treating age-related muscle conditions. Apelin receptor modulator...
Invention Apelin receptor modulators for treating age-related muscle conditions. Apelin receptor modulators...
Invention Inhibitors of nlrp3 inflammasome. The present disclosure relates to compounds of Formula I: tha...
2021 Invention Rage fusion proteins with improved stability and ligand binding affinity and uses thereof. The pr...
Invention Use of dp1 receptor antagonists for the treatment of viral respiratory tract infections and dysre...
Invention Hypoxia-inducible factor prolyl hydroxylase inhibitors for treating aging-related conditions. Th...
Invention Hypoxia-inducible factor prolyl hydroxylase inhibitors for treating aging-related conditions. The...
2018 Invention Drug repurposing based on deep embeddings of gene expression profiles. A deep learning model mea...
Invention Drug repurposing based on deep embeddings of gene expression profiles. A deep learning model meas...
Invention Survival prediction using methylomic profiles. In various embodiments, the present description re...
Invention Survival prediction using metabolomic profiles. In various embodiments, the present description r...